Table 3.
Brogardh et al. (2012) | Chan et al. (2012) | Choi et al. (2014) | Lau et al. (2012) | Liao et al. (2016) | Marin et al. (2013) | Pang et al. (2013) | Tankisheva et al. (2014) | Tihanyi et al. (2007) | van Nes et al. (2006) | Yule et al. (2016) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Eligibility criteria | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Random allocation | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Concealed allocation | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Baseline comparability | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Blinded subjects | Yes | Yes | No | No | No | No | No | No | No | No | Not Yet |
Blinded therapists | Yes | No | No | No | No | No | No | No | No | No | Not Yet |
Blinded assessors | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Not Yet |
Adequate follow-up | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Intention-to-treat analysis | Yes | No | Yes | Yes | Yes | Yes | Yes | No | No | Yes | Not Yet |
Between-group comparisons | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Point estimators and variability | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
Total PEDro score | 9 | 8 | 6 | 8 | 8 | 8 | 8 | 7 | 6 | 8 | Not Yet |
Sample size ≥ 50 | No | No | No | Yes | No | No | Yes | No | Yes | Yes | No |
Level of evidence | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 |